Position in IDYA
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$3,578,001
-$142,595 QoQ
Shares Held
107,383
-0.2% QoQ
Ownership
0.122%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 16.26048815920583.ToString("F0")%
Shared 0.ToString("F0")%
None 83.73951184079417.ToString("F0")%
Common Shares in IDYA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026RHUMBLINE ADVISERS holds $1,237,848,251 across 287 Biotechnology names. IDYA ranks #57 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
423,140 | $188,948,935 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,781 | $121,907,911 | |
| 3 | INCY |
Incyte Corp
|
693,665 | $65,287,749 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
195,277 | $64,611,300 | |
| 5 | INSM |
INSMED Inc
|
272,615 | $44,578,004 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
164,542 | $31,106,665 | |
| 7 | EXEL |
Exelixis, Inc.
|
723,931 | $31,049,400 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
1,113,266 | $30,837,468 |
All Filings in IDYA
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,578,001 | 107,383 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $3,720,596 | 107,625 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $3,397,195 | 124,851 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $2,756,751 | 131,149 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $2,038,278 | 124,437 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $2,918,517 | 113,561 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $3,579,079 | 112,976 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $3,714,532 | 105,797 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $4,230,470 | 96,410 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $3,058,670 | 85,966 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $2,125,862 | 78,794 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $1,809,077 | 76,982 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $950,267 | 69,211 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $1,163,497 | 64,034 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $800,875 | 53,678 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $690,096 | 50,007 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $447,398 | 39,982 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $901,795 | 38,147 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $898,777 | 35,260 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $616,497 | 29,371 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $437,288 | 18,608 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $245,266 | 17,519 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $171,695 | 13,670 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $189,646 | 13,346 | Shares | Sole | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||